14 Jan Congenital Hemophilia with Inhibitors
Posted at 16:13h
in
Author: Danyal Ladha, University of OttawaReviewer: Roy Khalife, University of Ottawa Objectives At the end of the self-assessment module, participants will be able to:Understand the mechanism of action of Emicizumab prophylaxis in adult Hemophilia A patients with inhibitors. Understand the indications for Emicizumab prophylaxis and benefits...